EmpNia has secured clearance from the US Food and Drug Administration (FDA) to market its eMotus product across hospitals and cancer centres in the US.
The eMotus system aims to address challenges faced by clinicians in managing respiratory motion during image-guided radiation therapy (IGRT). It employs a disposable sensor pad coupled with software, designed to provide real-time tracking of respiratory motion.
The system is said to be compatible with existing imaging and therapy equipment, allowing clinics to integrate the solution without extensive capital investment.
EmpNia chief medical officer Cliff Robinson said: “Effectively managing respiratory motion across all patient types and delivery systems, whether during imaging or radiation therapy, has long challenged clinicians and added unnecessary time and complexity.
“eMotus overcomes these challenges with a simple, reliable, and universally compatible solution that lets care teams stay focused on treating patients, not managing equipment.”
Established in 2020 in Minneapolis, Minnesota, EmpNia is engaged in developing medical technologies focused on radiation therapy and diagnostic imaging.
Pre-market evaluations of eMotus are said to have indicated significant improvements in workflow efficiency and accuracy in motion tracking. Its disposable sensor pad design simplifies operations by reducing setup time and negating the need for costly infrastructure changes or maintenance contracts, said the company.
EmpNia founder and CEO Manojeet Bhattacharya said: “Radiation oncology teams shouldn’t have to choose between precision and practicality.
“With FDA clearance of eMotus, we are delivering a motion management system that is easy to use, works for all patient types, integrates seamlessly with any setup, and is cost-effective thanks to our disposable sensor pad model.”
The target users of the eMotus system are radiation oncology professionals who manage patients undergoing image-guided radiation therapy. By facilitating better management of respiratory motion during treatment, eMotus aims to streamline clinical processes, thereby assisting care teams in focusing on patient care rather than equipment logistics.
